Target intelligence / Profile preview

Keratin, type I cytoskeletal 24 (KRT24)

Target
KRT24
Molecular classification
Intermediate filament protein, Type I keratin, Cytoskeletal protein
01

Overview

Keratin 24 (KRT24) is a type I intermediate filament protein expressed predominantly in differentiated epithelial tissues, especially the suprabasal layer of the corneal epithelium, with lower levels in epidermis and other squamous epithelia[3]. It plays a role in keratinocyte terminal differentiation, inhibition of cell cycle progression at G1/S, induction of senescence, autophagy, and apoptosis, and suppression of cell migration, possibly through PKCδ signaling[1]. KRT24 is not essential for cytoskeletal formation, but it likely contributes to the specialized properties of differentiated epithelial cells. It may serve as a marker of aging, differentiation, and has potential as a biomarker for certain skin and corneal conditions, but is not recognized as a therapeutic target or receptor at present[1][3].

Other names
Cytokeratin-24CK-24KA24K24MGC138169MGC138173FLJ20261Keratin-24Type I keratin-24Keratin 24KRT24
02

Mechanism of action

Not applicable, as there are no known drugs targeting KRT24. Mechanistic studies show it functions through the PKCδ signaling pathway affecting cell cycle arrest, apoptosis, and differentiation[1].

03

Biological functions

Structural support in epithelial cellsTerminal differentiation of keratinocytesRegulation of cell proliferation (inhibition)Induction of cellular senescence, autophagy, and apoptosisInhibition of cell migrationModulation of epithelial–mesenchymal transition (EMT)
04

Disease associations

Aging (biomarker for cellular aging and senescence)Skin differentiation disordersPotential tumor suppression (inhibits proliferation, migration, and induces apoptosis in keratinocytes)Possible relevance to psoriasis and corneal diseases
05

Biomarkers

Marker for terminal differentiation in keratinocytesPotential biomarker for cellular senescencePotential diagnostic marker for corneal diseases and epidermal differentiation

Beyond the preview

Go deeper on Keratin, type I cytoskeletal 24 (KRT24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin, type I cytoskeletal 24 (KRT24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call